Xiaoqing Wu

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Metastatic Breast Cancer

Binding Protein

Top Venues

Science translational medicine

Communications biology

Molecular oncology

University of Kansas

Southeast University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Kansas Jul 31 2016

United States

Assitant Research Professor :: Higuchi Biosciences Center

University of Kansas Apr 15 2012 - Jul 30 2016

United States

Postdoctoral Researcher :: Molecular Bioscience

Education History

Southeast University

China

PHD :: Chemistry and Chemical Engineering

Publications

Lanjing Wei, Qi Zhang, Cuncong Zhong, Lily He, Yuxia Zhang, Ahlam M Armaly, Jeffrey Aubé, Danny R Welch, Liang Xu, Xiaoqing Wu
Functional inhibition of the RNA-binding protein HuR sensitizes triple-negative breast cancer to chemotherapy. Molecular oncology (2023)
Peng Zhang, Xiaoqing Wu, Gulhumay Gardashova, Yang Yang, Yaohua Zhang, Liang Xu, Yong Zeng
Molecular and functional extracellular vesicle analysis using nanopatterned microchips monitors tumor progression and metastasis. Science translational medicine 12 (547) (2021)
Xiaoqing Wu, Gulhumay Gardashova, Lan Lan, Shuang Han, Cuncong Zhong, Rebecca T Marquez, Lanjing Wei, Spencer Wood, Sudeshna Roy, Ragul Gowthaman, John Karanicolas, Philip Gao, Dan A Dixon, Danny R Welch, Ling Li, Min Ji, Jeffrey Aube, Liang Xu
Targeting the interaction between RNA-binding protein HuR and FOXQ1 suppresses breast cancer invasion and metastasis. Communications biology 3 (1) (2020)